Clinical Trial Update: A Study of Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nimotuzumab with radiation therapy for brain metastases in metastatic non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: YM BioSciences | Conditions: Metastatic Non-Small Cell Lung Cancer | Phase 2 | Status: TERMINATED